R.PR
REGISTERED-PRINCIPAL REGISTER
07/21/2026
Back to search
Official data from USPTO
QUEREXA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
13
Latest update
07/21/2026
Trademark type
Word
Nice classes
5
Filing date
09/29/2025
Registration date
07/21/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/21/2026
Last transaction
07/21/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
82
Owner location
AU
Examiner
PEISECKI, MARK A
Law office
L50
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
PHARMAKO BIOTECHNOLOGIES PTY LIMITED
Representatives
No representative data.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biochemical reagents for medical or veterinary use; biological preparations for medical use namelymixed biological preparations for the prevention and treatment of nutritional deficiencies; biotechnological preparations for medical usemixed biological preparations for the prevention and treatment of nutritional deficiencies; dietary supplements for humans and animals; dietary supplements for pharmaceutical purposesantioxidants; dietetic food and substances adapted for medical or veterinary use; nutraceuticals for use as a dietary supplement; pharmaceutical preparations for the treatment of painswelling and inflammation; pharmaceutical products and preparationsdrug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical productsmedical and veterinary preparations for the treatment of cardiovascular disordersblood pressureneurological disordersdiabetesstomach ulcersurinary healthimmune system related diseases and disorders; pharmaceutical substances for the treatment of allergies; pharmaceutical products for treatment of infectious diseases and for use in oncology
Publications
History of USPTO decisions and trademark events.
13 publications found
PUBO
PUBLISHED FOR OPPOSITION
06/02/2026
GPNX
NOTIFICATION PROCESSED BY IB
05/28/2026
NPUB
NOTICE OF PUBLICATION
05/27/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/13/2026
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/13/2026
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
02/03/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/19/2026
DOCK
ASSIGNED TO EXAMINER
01/13/2026
MAFR
APPLICATION FILING RECEIPT MAILED
12/05/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/05/2025
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
12/05/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/20/2025
Continuous trademark protection
Get notified about every new filing that threatens QUEREXA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.